| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.53 (Beat by $0.0742) |
| EPS GAAP Actual | $0.53 (Beat by $0.0742) |
| Revenue Actual | $1.17953B |
| Revenue Surprise | Beat by $1179.53M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 3.2 | 21.28 | 3.12363 | 3.26198 | 3 |
| Dec 2028 | 2.7 | 25.22 | 2.61463 | 2.78862 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.53 | 0.53 | 1.17953B | 5.22% | 1179.53M |
| FQ2 2025 (Jun 2025) | 0.59 | 0.59 | 1.21415B | 6.67% | 1214.15M |
| FQ1 2025 (Mar 2025) | 0.45 | 0.45 | 1.16074B | 5.47% | 1160.74M |
| FQ4 2024 (Dec 2024) | 0.44 | 0.44 | 1.10742B | 5.35% | 1107.42M |
| FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 1.11793B | 100% | 1117.93M |
| FQ2 2024 (Jun 2024) | 0.53 | 0.53 | 1.13314B | 100% | 1133.14M |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 1.09729B | 100% | 1097.29M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 1.04812B | 100% | 1048.12M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.5765 | -- | 0.56784 | 0.59037 | 8 |
| FQ3 2028 (Sep 2028) | 0.7521 | -- | 0.74081 | 0.77019 | 5 |
| FQ2 2028 (Jun 2028) | 0.7385 | -- | 0.72741 | 0.75627 | 5 |
| FQ1 2028 (Mar 2028) | 0.5271 | -- | 0.51918 | 0.53978 | 10 |
| FQ4 2027 (Dec 2027) | 0.5469 | -- | 0.53897 | 0.56268 | 6 |
| FQ3 2027 (Sep 2027) | 0.9 | -- | 0.88144 | 0.92127 | 12 |
| FQ2 2027 (Jun 2027) | 0.82 | -- | 0.80309 | 0.83937 | 7 |
| FQ1 2027 (Mar 2027) | 0.7 | -- | 0.68557 | 0.71654 | 7 |
| FQ4 2026 (Dec 2026) | 0.43345 | -- | 0.42265 | 0.45051 | 13 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.99B | -- | 1.97B | 2.03B | 4 |
| FQ3 2028 (Sep 2028) | 1.92B | -- | 1.89B | 1.95B | 4 |
| FQ2 2028 (Jun 2028) | 1.84B | -- | 1.82B | 1.87B | 4 |
| FQ1 2028 (Mar 2028) | 1.77B | -- | 1.75B | 1.8B | 4 |
| FQ4 2027 (Dec 2027) | 1.37B | -- | 1.35B | 1.4B | 5 |
| FQ3 2027 (Sep 2027) | 1.5B | -- | 1.48B | 1.53B | 7 |
| FQ2 2027 (Jun 2027) | 1.48B | -- | 1.46B | 1.51B | 11 |
| FQ1 2027 (Mar 2027) | 1.42B | -- | 1.4B | 1.45B | 7 |
| FQ4 2026 (Dec 2026) | 1.35B | -- | 1.33B | 1.39B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.53 | 0.53 | 100% | |
| FQ2 2025 (Jun 2025) | 0.59 | 0.59 | 100% | |
| FQ1 2025 (Mar 2025) | 0.45 | 0.45 | 100% | |
| FQ4 2024 (Dec 2024) | 0.44 | 0.44 | 100% | |
| FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 100% | |
| FQ2 2024 (Jun 2024) | 0.53 | 0.53 | 100% | |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.18B | $1179.53M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.21B | $1214.15M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.16B | $1160.74M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.11B | $1107.42M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.12B | $1117.93M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.13B | $1133.14M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.1B | $1097.29M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.05B | $1048.12M | 100% |